PHARMING (PHARM ) | Finanzwire

Basculer en Français

8295	Companies
114833	Keywords
55274	Articles
62430	Press releases

Home
Companies
PHARMING

BRIEF

published on 10/29/2024 at 14:57, 22 days 19 hours ago

Pharming Group NV: Promising Outlook Amid Executive Change

Sales Growth Executive Change Profitability Outlook Leniolisib Pharming Group
PRESS RELEASE

published on 10/29/2024 at 14:52, 22 days 19 hours ago

Original-Research: Pharming Group NV (von First Berlin Equity Research GmbH): Buy
First Berlin Equity Research raises price target for Pharming Group NV after Q3/24 results. CEO not seeking reappointment unrelated to business. Market undervaluing APDS drug sales potential. Expect significant revenue growth

Revenue Growth First Berlin Equity Research Pharming Group NV Q3/24 Results APDS Drug
BRIEF

published on 08/26/2024 at 16:01, 2 months 25 days ago

First Berlin Equity Research Reiterates 'Buy' Rating for Pharming Group NV

Price Target Equity Research Patient Growth Pharming Leniolisib
PRESS RELEASE

published on 08/26/2024 at 15:56, 2 months 25 days ago

Original-Research: Pharming Group NV (von First Berlin Equity Research GmbH): Buy
First Berlin Equity Research updates recommendation on Pharming Group NV to Buy with a target price of €1.60. Q2/24 showed strong performance with revenue up 35% yoy and 33% qoq

Revenue First Berlin Equity Research Buy Recommendation Q2/24 Pharming Group NV
PRESS RELEASE

published on 08/09/2023 at 14:46, 1 year 3 months ago

Original-Research: Pharming Group NV (von First Berlin Equity Research GmbH): Buy
PRESS RELEASE

published on 07/18/2023 at 11:56, 1 year 4 months ago

Original-Research: Pharming (von First Berlin Equity Research GmbH): Buy

Accesswire

Published on 11/21/2024 at 10:03, 41 minutes ago

Pixotope Launches Revolutionary AI-Powered Graphics Integration Tool for Broadcast Industry
Published on 11/21/2024 at 10:00, 44 minutes ago

BluSky Carbon JV Entity BluMountain Enters into JV Partnership in Southeastern USA
Published on 11/21/2024 at 09:00, 1 hour 44 minutes ago

ProScore Announces Domestic Content Solution for Inflation Reduction Act Requirements
Published on 11/21/2024 at 00:35, 10 hours 9 minutes ago

Vision Marine Technologies Establishes a Strategic Hub for Electric Boat Sales, Rentals, and Distribution, Marking a Milestone at Dania Pointe’s Grand Opening of Aileron Residences
Published on 11/21/2024 at 00:25, 10 hours 19 minutes ago

Biomind Labs Welcomes U.S. Policy Shift as a Historic Milestone for Psychedelic Therapies

View all ACCESSWIRE

EQS Group

Published on 11/21/2024 at 10:30, 14 minutes ago

MS Industrie AG publishes unaudited key figures for the first 3 quarters 2024
Published on 11/21/2024 at 10:04, 39 minutes ago

Supervisory Board appoints Carsten Schmitt as new CFO
Published on 11/21/2024 at 10:02, 42 minutes ago

Supervisory Board appoints Carsten Schmitt as new CFO
Published on 11/21/2024 at 10:00, 44 minutes ago

Nabaltec AG continues solid earnings performance in third quarter of 2024
Published on 11/21/2024 at 10:00, 44 minutes ago

Deutsche Beteiligungs AG: Successful final closing of DBAG ECF IV

Les Echos

Published on 11/21/2024 at 06:58, 3 hours 46 minutes ago

Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/20/2024 at 19:20, 15 hours 24 minutes ago

Peugeot Invest Board of Directors to evolve following the May 2025 Annual General Meeting
Published on 11/20/2024 at 17:45, 16 hours 59 minutes ago

MEDESIS PHARMA HAS COMPLETED ITS CLINICAL STUDY FOR THE TREATMENT OF ALZHEIMER'S DISEASE WITH NANOLITHIUM
Published on 11/20/2024 at 17:45, 16 hours 59 minutes ago

Disclosure of Share Capital and Voting Rights Outstanding as of October 31, 2024
Published on 11/20/2024 at 07:45, 1 day 2 hours ago

Gimv sells to Fremman Capital a majority stake in outpatient rehabilitation specialist rehaneo

View all LES ECHOS COMFI WIRE